ISE Webinar on GLP-1
January 26, 2021, 4PM CET
What is the role of GLP-1 RAs in the current landscape of incretin therapies for T2D?
We are close to that time of the year when we all need a (screen) break, but education in endocrinology is our priority and we are working hard to start the new year with high-quality educational offerings.
For now, we invite you to save the date in your calendars to join an interactive discussion with the top experts in the field and explore the role of GLP-1 RAs in the current landscape of incretin therapies for type 2 diabetes.
During this webinar, Dr Abbas Raza (Pakistan), Dr Alvin Powers (USA), Dr David D’Alessio (USA), and Dr Boris Draznin (USA) will engage in an interactive case-based discussion around Diabetes Management, giving you the opportunity to ask your questions during a Meet the Expert virtual session.
After the webinar session, you will be invited to solve a CME-accredited case study on the ISE Global Education Hub to apply what you learned.
This activity is supported by an unrestricted grant by Novo Nordisk.
Dit bericht is afkomstig uit de ISE Nieuwsbrief.